- Presentations
- 4
- Markets
- 1
Glyrx-pf is a brand of Glycopyrrolate marketed by Exela Pharma Sciences, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Glycopyrrolate
- Brand owner
- Exela Pharma Sciences
- Registered in
- United States
- Strengths and forms
- 0.2 mg/1 mL injection, 0.4 mg/2 mL injection, 0.6 mg/3 mL injection, 1 mg/5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Glyrx-pf 0.2 mg/1 mL injectionIntramuscular, intravenous | Exela Pharma Sciences | US FDA | Available on request |
| Glyrx-pf 0.4 mg/2 mL injectionIntramuscular, intravenous | Exela Pharma Sciences | US FDA | Available on request |
| Glyrx-pf 0.6 mg/3 mL injectionIntramuscular, intravenous | Exela Pharma Sciences | US FDA | Available on request |
| Glyrx-pf 1 mg/5 mL injectionIntramuscular, intravenous | Exela Pharma Sciences | US FDA | Available on request |
Equivalent brands
Other brands of Glycopyrrolate.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Glyrx-pf
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.